Assessment of cold chain equipments and their management in government health facilities in a District of Delhi: A cross-sectional descriptive study.

Chilly chain equipments (CCEs) at well being services (HFs) are an important a part of the immunization provide chain (ISC). The CCEs in authorities HFs of Delhi had been by no means assessed utilizing the World Well being Group-United Nations Kids’s Fund (WHO-UNICEF) Efficient Vaccine Administration (EVM) software besides that of state vaccine retailer throughout Nationwide EVM evaluation 2013.

The target of the examine was to evaluate the CCEs and their administration in authorities HFs utilizing the WHO-UNICEF EVM software in a district of Delhi. The evaluation was executed throughout December 2017-March 2018 in a single randomly chosen district of Delhi.

EIF3J Antibody
45974-100ul	SAB	100ul	EUR 302.4

EIF3J Antibody
45974-50ul	SAB	50ul	EUR 224.4

EIF3J Antibody
47099-100ul	SAB	100ul	EUR 302.4

EIF3J Antibody
ABD9509	Lifescience Market	100 ug	EUR 525.6

EIF3J siRNA
20-abx915181	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

EIF3J siRNA
20-abx915182	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

EIF3J Antibody
AF6761	Affbiotech	100ul	EUR 420

EIF3J Antibody
1-CSB-PA070117	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/40000

EIF3J Antibody
1-CSB-PA007539GA01HU	Cusabio	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF

EIF3J Antibody
1-CSB-PA007539LA01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

EIF3J Antibody
DF9509	Affbiotech	200ul	EUR 420

EIF3J Blocking Peptide
20-abx061163	Abbexa	EUR 343.20 EUR 510.00	1 mg 5 mg

EIF3J Rabbit pAb
A8637-100ul	Abclonal	100 ul	EUR 369.6

EIF3J Rabbit pAb
A8637-200ul	Abclonal	200 ul	EUR 550.8

EIF3J Rabbit pAb
A8637-20ul	Abclonal	20 ul	EUR 219.6

EIF3J Rabbit pAb
A8637-50ul	Abclonal	50 ul	EUR 267.6

EIF3J Conjugated Antibody
C47099	SAB	100ul	EUR 476.4

EIF3J Conjugated Antibody
C45974	SAB	100ul	EUR 476.4

EIF3J Blocking Peptide
DF9509-BP	Affbiotech	1mg	EUR 234

Anti-EIF3J antibody
PAab02711	Lifescience Market	100 ug	EUR 426

anti- EIF3J antibody
FNab02711	FN Test	100µg	EUR 606.3
Description: Antibody raised against EIF3J

Anti-EIF3J antibody
STJ113577	St John's Laboratory	100 µl	EUR 332.4
Description: This gene encodes a core subunit of the eukaryotic initiation factor 3 complex, which participates in the initiation of translation by aiding in the recruitment of protein and mRNA components to the 40S ribosome. There are pseudogenes for this gene on chromosomes 1, 3, and 9. Alternative splicing results in multiple transcript variants encoding different isoforms.

EIF3J protein (His tag)
80R-2025	Fitzgerald	50 ug	EUR 508.8
Description: Recombinant human EIF3J protein (His tag)

Human EIF3J shRNA Plasmid
20-abx955704	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg

Phospho-EIF3J (Ser127) Antibody
AF3761	Affbiotech	100ul	EUR 540

Rat EIF3J shRNA Plasmid
20-abx991229	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg

EIF3J Antibody, HRP conjugated
1-CSB-PA007539LB01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

EIF3J Antibody, FITC conjugated
1-CSB-PA007539LC01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

EIF3J Antibody, Biotin conjugated
1-CSB-PA007539LD01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

EIF3J ELISA KIT|Human
EF009345	Lifescience Market	96 Tests	EUR 826.8

Bovine EIF3J ELISA KIT
ELI-26894b	Lifescience Market	96 Tests	EUR 1113.6

Human EIF3J ELISA KIT
ELI-26895h	Lifescience Market	96 Tests	EUR 988.8

Chicken EIF3J ELISA KIT
ELI-47291c	Lifescience Market	96 Tests	EUR 1113.6

Mouse Eif3j ELISA KIT
ELI-09166m	Lifescience Market	96 Tests	EUR 1038

EIF3J Recombinant Protein (Rat)
RP199367	ABM	100 ug	Ask for price

EIF3J Recombinant Protein (Human)
RP056415	ABM	100 ug	Ask for price

EIF3J Recombinant Protein (Mouse)
RP131294	ABM	100 ug	Ask for price

Eif3j ORF Vector (Rat) (pORF)
ORF066457	ABM	1.0 ug DNA	EUR 607.2

EIF3J ORF Vector (Human) (pORF)
ORF018806	ABM	1.0 ug DNA	EUR 486

Eif3j ORF Vector (Mouse) (pORF)
ORF043766	ABM	1.0 ug DNA	EUR 607.2

Eif3j sgRNA CRISPR Lentivector set (Rat)
K7490601	ABM	3 x 1.0 ug	EUR 406.8

EIF3J sgRNA CRISPR Lentivector set (Human)
K0668401	ABM	3 x 1.0 ug	EUR 406.8

Eif3j sgRNA CRISPR Lentivector set (Mouse)
K3550601	ABM	3 x 1.0 ug	EUR 406.8

Eif3j sgRNA CRISPR Lentivector (Rat) (Target 1)
K7490602	ABM	1.0 ug DNA	EUR 184.8

Eif3j sgRNA CRISPR Lentivector (Rat) (Target 2)
K7490603	ABM	1.0 ug DNA	EUR 184.8

Eif3j sgRNA CRISPR Lentivector (Rat) (Target 3)
K7490604	ABM	1.0 ug DNA	EUR 184.8

EIF3J sgRNA CRISPR Lentivector (Human) (Target 1)
K0668402	ABM	1.0 ug DNA	EUR 184.8

EIF3J sgRNA CRISPR Lentivector (Human) (Target 2)
K0668403	ABM	1.0 ug DNA	EUR 184.8

EIF3J sgRNA CRISPR Lentivector (Human) (Target 3)
K0668404	ABM	1.0 ug DNA	EUR 184.8

Eif3j sgRNA CRISPR Lentivector (Mouse) (Target 1)
K3550602	ABM	1.0 ug DNA	EUR 184.8

Eif3j sgRNA CRISPR Lentivector (Mouse) (Target 2)
K3550603	ABM	1.0 ug DNA	EUR 184.8

Eif3j sgRNA CRISPR Lentivector (Mouse) (Target 3)
K3550604	ABM	1.0 ug DNA	EUR 184.8

EIF3J Protein Vector (Human) (pPB-C-His)
PV075221	ABM	500 ng	EUR 662.4

EIF3J Protein Vector (Human) (pPB-N-His)
PV075222	ABM	500 ng	EUR 662.4

EIF3J Protein Vector (Human) (pPM-C-HA)
PV075223	ABM	500 ng	EUR 662.4

EIF3J Protein Vector (Human) (pPM-C-His)
PV075224	ABM	500 ng	EUR 662.4

EIF3J Protein Vector (Mouse) (pPB-C-His)
PV175062	ABM	500 ng	EUR 723.6

EIF3J Protein Vector (Mouse) (pPB-N-His)
PV175063	ABM	500 ng	EUR 723.6

EIF3J Protein Vector (Mouse) (pPM-C-HA)
PV175064	ABM	500 ng	EUR 723.6

EIF3J Protein Vector (Mouse) (pPM-C-His)
PV175065	ABM	500 ng	EUR 723.6

EIF3J 3'UTR Luciferase Stable Cell Line
TU006746	ABM	1.0 ml	EUR 1825.2

Eif3j 3'UTR GFP Stable Cell Line
TU253889	ABM	1.0 ml	Ask for price

Eif3j 3'UTR Luciferase Stable Cell Line
TU105722	ABM	1.0 ml	Ask for price

EIF3J 3'UTR GFP Stable Cell Line
TU056746	ABM	1.0 ml	EUR 1825.2

Eif3j 3'UTR Luciferase Stable Cell Line
TU203889	ABM	1.0 ml	Ask for price

Eif3j 3'UTR GFP Stable Cell Line
TU155722	ABM	1.0 ml	Ask for price

EIF3J Protein Vector (Rat) (pPB-C-His)
PV265826	ABM	500 ng	EUR 723.6

EIF3J Protein Vector (Rat) (pPB-N-His)
PV265827	ABM	500 ng	EUR 723.6

EIF3J Protein Vector (Rat) (pPM-C-HA)
PV265828	ABM	500 ng	EUR 723.6

EIF3J Protein Vector (Rat) (pPM-C-His)
PV265829	ABM	500 ng	EUR 723.6

Recombinant Human EIF3J Protein, His, E.coli-10ug
QP11768-10ug	EnQuireBio	10ug	EUR 241.2

Recombinant Human EIF3J Protein, His, E.coli-1mg
QP11768-1mg	EnQuireBio	1mg	EUR 6301.2

Recombinant Human EIF3J Protein, His, E.coli-2ug
QP11768-2ug	EnQuireBio	2ug	EUR 186

EIF3J Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
LV679279	ABM	1.0 ug DNA	EUR 616.8

EIF3J Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
LV679283	ABM	1.0 ug DNA	EUR 616.8

EIF3J Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
LV679284	ABM	1.0 ug DNA	EUR 616.8

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody
20-abx133581	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody
20-abx123586	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody
20-abx112377	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody
20-abx315695	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody
20-abx327824	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody
abx232711-100ug	Abbexa	100 ug	EUR 577.2

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody
20-abx215117	Abbexa	EUR 510.00 EUR 410.40	100 ug 50 ug

EIF3J Eukaryotic Translation Initiation Factor 3J Human Recombinant Protein
PROTO75822	BosterBio	Regular: 10ug	EUR 380.4
Description: EIF3J Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 210 amino acids (70-258) and having a molecular mass of 24kDa (Molecular weight on SDS-PAGE will appear higher).;EIF3J is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody (HRP)
20-abx315696	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody (FITC)
20-abx315697	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody (Biotin)
20-abx315698	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
K7490605	ABM	3 x 1.0 ug	EUR 451.2

EIF3J sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K0668405	ABM	3 x 1.0 ug	EUR 451.2

Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
K3550605	ABM	3 x 1.0 ug	EUR 451.2

Human Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) ELISA Kit
abx387099-96tests	Abbexa	96 tests	EUR 1093.2

EIF3J Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
LV679280	ABM	1.0 ug DNA	EUR 616.8

EIF3J Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
LV679281	ABM	1.0 ug DNA	EUR 686.4

EIF3J Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
LV679282	ABM	1.0 ug DNA	EUR 686.4

Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
K7490606	ABM	1.0 ug DNA	EUR 200.4

Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
K7490607	ABM	1.0 ug DNA	EUR 200.4

Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
K7490608	ABM	1.0 ug DNA	EUR 200.4

EIF3J sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
K0668406	ABM	1.0 ug DNA	EUR 200.4

EIF3J sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
K0668407	ABM	1.0 ug DNA	EUR 200.4

EIF3J sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
K0668408	ABM	1.0 ug DNA	EUR 200.4

Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
K3550606	ABM	1.0 ug DNA	EUR 200.4

Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K3550607	ABM	1.0 ug DNA	EUR 200.4

Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)
K3550608	ABM	1.0 ug DNA	EUR 200.4

Pattern dimension and website choice had been executed utilizing the WHO EVM website choice software. A complete of 29 HFs had been assessed together with District Vaccine Retailer. Questions on CCEs in EVM software 1.0.9 had been used for knowledge assortment.Out of 56 electrical CCEs, 8.9% had been nonfunctional, 48.2% had been noncompliant with WHO requirements, 5.4% weren’t chlorofluorocarbon free, 4.7% didn’t have temperature monitoring system, and 18.8% didn’t have stabilizer.

Eighty-six % of passive containers had been compliant with the WHO requirements. The storage capability {of electrical} vaccine storage tools was inadequate in 3.4%, passive container capability in 65.5%, and ice packs preparation and storage capability in 24.1% of HFs. There was no deliberate preventive upkeep of CCEs and no commonplace working procedures for emergency occasion administration.

There was a scarcity of vaccine storage, ice packs preparation and storage, and passive container capability. Many CCEs utilized in ISC of assessed websites had been noncompliant to the WHO requirements. There was no PPM of CCEs and no pointers for emergency occasion administration.